Substance Withdrawal SyndromeTobacco Use DisorderSmoking CessationMorphine DependenceTobacco Use Cessation ProductsNicotineCannabisSubstance PAlcohol Withdrawal DeliriumNaloxoneOpioid-Related DisordersNarcotic AntagonistsAlcohol Withdrawal SeizuresNicotinic AgonistsBuprenorphineBupropionMarijuana AbuseNeonatal Abstinence SyndromeBehavior, AddictiveSubstance-Related DisordersAlcoholismSmokingMorphineChlormethiazoleAnhedoniaIrritable MoodMethadoneDrug ToleranceHeroin DependenceNarcoticsAnxietyChewing GumEthanolOpiate Substitution TreatmentSodium OxybateClomipramineTime FactorsBenzodiazepinesCotinineQuestionnairesAdministration, CutaneousDouble-Blind MethodAnalgesics, OpioidCarbon MonoxideTreatment OutcomeCentral Nervous System DepressantsCarbamazepinePsychiatric Status Rating ScalesAffectAnti-Anxiety AgentsHypnotics and SedativesRecurrenceNaltrexoneSeverity of Illness IndexDose-Response Relationship, DrugDronabinolMotivationBenzazepinesDiagnostic and Statistical Manual of Mental DisordersClonidineCannabinoidsBehavior, AnimalAnalysis of VarianceValproic AcidDopamine Uptake InhibitorsAnticonvulsantsQuinoxalinesAttention Deficit Disorder with HyperactivityProspective StudiesRats, Sprague-DawleyStress, PsychologicalDrug Administration SchedulePlacebosFollow-Up StudiesSelf ReportSubstance Abuse Treatment CentersReceptors, Neurokinin-1DepressionDrug InteractionsAlcohol DrinkingPilot ProjectsSymptom AssessmentBrainReceptors, NicotinicWithholding TreatmentThiobarbituric Acid Reactive SubstancesDiagnosis, Dual (Psychiatry)Risk FactorsHazardous SubstancesPainHumic SubstancesPrevalenceLongitudinal StudiesBehavioral SymptomsAffective SymptomsComorbidityCross-Sectional StudiesTachykininsStreet DrugsDepressive Disorder